The weight-loss drug gold rush is getting larger  Axios Brought to you by Google News. Read the rest of the article here.

Pfizer pulls the plug on weight loss drug  Axios Pfizer’s twice-daily weight loss pill joins a long list of obesity drug flops  CNBC Pfizer Shares Drop as It Ends Study of Weight-Loss Pill Due to Patient Side Effects  Investopedia Brought to you by Google News. Read the rest of the article here.

Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects  CNBC Pfizer pulls the plug on weight loss drug  Axios Pfizer drops twice-daily version of obesity pill over side effects  Reuters Brought to you by Google News. Read the rest of the article here.

How ‘cozy cardio’ helped a former weight-loss influencer rethink exercise  Business Insider Brought to you by Google News. Read the rest of the article here.

Mounjaro Works Better for Weight Loss Than Ozempic  PEOPLE Lilly’s Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds  Reuters Users of diabetes drug Mounjaro lost more weight than those on Ozempic, large study finds  CNN Brought to you by Google News. Read the rest of the article here.

Ozempic and Wegovy have upended the diet industry. So why is the WeightWatchers CEO betting the company’s future on them?  CNN Brought to you by Google News. Read the rest of the article here.

Lilly’s Mounjaro leads to more and faster weight loss than Novo obesity drug, data analysis finds  Reuters Brought to you by Google News. Read the rest of the article here.

Sharon Osbourne Says Ozzy Osbourne ‘Doesn’t Like’ Her Weight Loss  PEOPLE Brought to you by Google News. Read the rest of the article here.

Experimental weight loss drug could help treat fatty liver disease in people with obesity, study finds  Fox News Brought to you by Google News. Read the rest of the article here.

Mom shares epic weight loss transformation by kicking one bad habit  New York Post Brought to you by Google News. Read the rest of the article here.